/Companies

RXLive

St. Petersburg, US · Founded 2018 · 4 known investors

Find your way into RXLive

Sign up to find every way you can get introduced to RXLive

  • Your email: who you already know at RXLive, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the RXLive team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

RxLive provides telehealth pharmacist services, software, and analytics to integrate clinical pharmacists into the healthcare team under a "value-based pharmacy" model. It serves patients, healthcare providers, employers, and payers to reduce medication spending and improve clinical outcomes.

Founders & leadership

ME
MARK ENGELENNamed on SEC filing

Board

KG
KRISTIN GRECOBoard director
LD
LORAINE DAUGHERTYBoard director
SM
SEAN McNAMARABoard director

Investors · 4

Also in the syndicate · 1

Cardinal Health

Reported raises · per SEC filings

Form D private placements

$10.1M disclosed across 5 rounds · 2018–2022

▶$1.6MraisedSep 2022 · 8 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • ELIOT HELLERDirector
  • SEAN MCNAMARADirector
  • MARK ENGELENExecutive Officer, Director
  • LORAINE DAUGHERTYDirector
  • KRISTIN GRECODirector
Offering amount
$1.6M
Amount sold
$1.6M
Minimum investment
$25K
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedSep 2022 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • MAR ENGELENExecutive Officer, Director
  • ELIOT HELLERDirector
  • LORAINE DAUGHERTYDirector
  • SEAN MCNAMARADirector
  • KRISTIN GRECODirector
Offering amount
$5M
Amount sold
$5M
Minimum investment
$100K
First sale
Apr 2022
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedApr 2021 · 24 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • KRISTIN GRECODirector
  • LORAINE DAUGHERTYDirector
  • SEAN McNAMARADirector
  • MARK ENGELENExecutive Officer, Director
Offering amount
$2M
Amount sold
$2M
Minimum investment
$12.5K
First sale
Jul 2020
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$850KraisedOct 2019 · 6 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sean McNamaraDirector
  • Loraine DaughertyDirector
  • Mark EngelenExecutive Officer, Director
Offering amount
$1M
Amount sold
$850K
Minimum investment
$25K
First sale
May 2019
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$600KraisedJun 2018 · 9 investors · Other Technology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark EngelenExecutive Officer, Director
Offering amount
$1M
Amount sold
$600K
Minimum investment
$25K
First sale
Jun 2018
Incorporated
Corporation, Delaware, 2018
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does RXLive do?
RxLive provides telehealth pharmacist services, software, and analytics to integrate clinical pharmacists into the healthcare team under a "value-based pharmacy" model. It serves patients, healthcare providers, employers, and payers to reduce medication spending and improve clinical outcomes.
Who are RXLive's investors?
RXLive's investors include Axial Capital Partners, Dreamit Ventures, SpringTide Ventures.
How much funding has RXLive raised?
RXLive has disclosed $10.1M raised across 5 rounds.
Where is RXLive headquartered?
RXLive is headquartered in St. Petersburg, US.